SJN
Sung Ji Nam Scotiabank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
28%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
77.8%
Neutral
22.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sector Outperform
Maintained
| $60 |
33%
downside
| 2 | +45% |
0
%
| 31 Jul ‘25 8 months ago |
|
|
|
Sector Outperform
Maintained
| $75 |
38%
upside
| 1 | -10% |
0
%
| 11 Jul ‘25 9 months ago |
|
|
|
Sector Outperform
Upgraded
| $275 |
55%
upside
| 1 | -7.1% |
0
%
| 11 Jul ‘25 9 months ago |
|
|
|
Sector Outperform
Upgraded
| $590 |
26%
upside
| 2 | +9.5% |
0
%
| 11 Jul ‘25 9 months ago |
|
|
|
Sector Perform
Downgraded
| $125 |
2%
downside
| 1 | – |
–
| 11 Jul ‘25 9 months ago |
|
|
|
Sector Outperform
Maintained
| $40 |
64%
upside
| 1 | +57% |
0
%
| 21 May ‘25 11 months ago |
|
|
|
Sector Outperform
Maintained
| $40 |
276%
upside
| 1 | +223% |
0
%
| 21 May ‘25 11 months ago |
|
|
|
Sector Perform
Downgraded
| $6 |
26%
upside
| 2 | -50% |
0
%
| 21 May ‘25 11 months ago |
|